|
|
Characterization of amyloid-B:a7B2-nicotinic acetylcholine receptor interactions relevant to Alzheimers disease |
| 1 R21 AG067029-01 |
LUKAS, RONALD J |
NIA |
2020 |
|
|
Are the impairments of arginine metabolism as found in Alzheimers disease also present in patients developing post-operative delirium and cognitive decline? |
| 1 R21 AG067083-01 |
GRAHAM, STEWART F |
NIA |
2020 |
|
|
Identifying Metabolomic Risk Factors in Plasma and Cerebrospinal Fluid for Alzheimers Disease |
| 1 R21 AG067092-01 |
LU, QIONGSHI |
NIA |
2020 |
|
|
C. Elegans as a Model of Cell Senescence and Alzheimers Disease |
| 1 R21 AG067147-01 |
JOHNSON, THOMAS E |
NIA |
2020 |
|
|
Dissecting connections between age, health and Alzheimers disease |
| 1 R21 AG067317-01 |
TISSENBAUM, HEIDI A |
NIA |
2020 |
|
|
Neural Aging and A Toxicity Assessments, a Fly Pharmacology-Molecular AD Model |
| 1 R21 AG067334-01 |
FINLEY, KIM D |
NIA |
2020 |
|
|
Personalized predictions of biomarker progression in Alzheimers disease |
| 1 R21 AG067442-01 |
WEICKENMEIER, JOHANNES |
NIA |
2020 |
|
|
Mechanism and importance of innate immune activation in a Drosophila GBA mutant model of Parkinsons disease |
| 1 R21 AG068356-01 |
PALLANCK, LEO J |
NIA |
2020 |
|
|
Sleep metrics from machine learning for Alzheimers disease diagnostics |
| 1 R21 AG068890-01 |
DUTTA, JOYITA |
NIA |
2020 |
|
|
Investigating nucleo-cytoplasmic partitioning in Alzheimers disease and aging |
| 1 R21 AG068922-01 |
LAPIERRE, LOUIS RENE |
NIA |
2020 |
